Onno Akkerman

Onno Akkerman is a researcher at the University of Groningen's Faculty of Medical Sciences, affiliated with the Microbes in Health and Disease research group. His work focuses on the pharmacokinetics/pharmacodynamics of tuberculosis (TB) drugs, inhalation-based antimicrobial therapies, and holistic approaches to TB treatment.

His research aligns with UN Sustainable Development Goals for health and well-being, with expertise in drug resistance, therapeutic drug monitoring, and pulmonary infections. Recent publications analyze TB treatment in ICU settings, MDR-TB in pediatrics, and novel diagnostics like sweat tests.

Key trends in his 2024–2025 articles include Lung Transplantation Complications, Host-directed TB Therapy, and International Collaboration. He received a €50,000 grant (2021) and the St. Northern Netherlands Beatrixoord Prize (2019).

He actively engages in professional presentations, including chairing symposiums on short regimens for drug-resistant TB and participating in the ERS Congress 2024. His media appearances highlight innovations such as sweat testing for medication adherence and fingerprint antibiotic detection.